You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory B-Cell Non-Hodgkin Lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

Not yet recruiting
  • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
  • (no location specified)
Mar 23, 2023

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Trial in Suzhou (Obinutuzumab, Zanubrutinib, Lenalidomide)

Enrolling by invitation
  • Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Mar 22, 2023

B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • (no location specified)
Aug 7, 2023

Lymphoma, Non-Hodgkin Trial in Perth (DZD8586)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Perth, Western Australia, Australia
    Linear Clinical Research Ltd
Apr 20, 2023

Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)

Completed
Has Results
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • Isehara, Kanagawa, Japan
  • +1 more
Apr 6, 2022

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

Not yet recruiting
  • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
  • JS203 for Injection
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 11, 2022

Lymphoma, Non-Hodgkin Trial in China (DZD8586)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Beijing, Beijing, China
  • +5 more
Apr 25, 2023

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

Recruiting
  • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
  • BAFFR-CAR T cells
  • Duarte, California
    City of Hope Medical Center
Oct 18, 2022

Non Hodgkin Lymphoma Trial in New York, Clayton, Frankston (IPH6501)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 12, 2023

Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Aug 19, 2022

Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Hangzhou (RD14-01 cell infusion)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • RD14-01 cell infusion
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jul 6, 2022

LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
    • (no location specified)
    Sep 19, 2023

    B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

    Recruiting
    • B Cell Non-Hodgkin's Lymphoma
    • CD19/CD20-directed CAR-T cells
    • Duarte, California
      City of Hope Medical Center
    Aug 10, 2022

    Non-Hodgkin's Lymphoma Trial (MBS303)

    Not yet recruiting
    • Non-Hodgkin's Lymphoma
    • (no location specified)
    Apr 6, 2023

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Suzhou (Selinexor, Flu, CTX)

    Recruiting
    • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 3, 2022

    B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Korea, Republic of, United

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • +3 more
    • Tampa, Florida
    • +8 more
    Oct 17, 2022

    Lymphoma, Non-Hodgkin Trial in Worldwide (RO7443904, Glofitamab, Obinutuzumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • New York, New York
    • +7 more
    Jan 11, 2023

    B-cell Non-Hodgkin's Lymphoma Trial in Shanghai (Human CD19Targeted T Cells Injection)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • Human CD19Targeted T Cells Injection
    • Shanghai, Shanghai, China
      Zhongshan Hospital, Fudan University
    Jun 29, 2022

    Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non Hodgkin's Lymphoma
    • Allogenic CD19-CAR-γδT cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Jan 31, 2023

    B-cell Non Hodgkin Lymphoma Trial in Seoul (AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

    Recruiting
    • B-cell Non Hodgkin Lymphoma
    • AT101(Anti-CD19 Chimeric Antigen Receptor T cell)
    • Seoul, Korea, Republic of
      Asan Medical Center
    May 24, 2022

    Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma
    • BTK inhibitor
    • PD-1 inhibitor
    • Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    May 20, 2023

    B-cell Non-Hodgkin's Lymphoma Trial in Hangzhou (CD19-CAR-DNT cells)

    Recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • CD19-CAR-DNT cells
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jul 6, 2022